Dietary Polyunsaturates, Vascular Function and Prostaglandins

  • Howard Knapp
  • Deborah Gregory
  • Sharina Nolan

Abstract

The high prevalence of certain cancers, atherosclerosis and hypertension in Europe and North America has been closely linked to the high-fat diet consumed by these populations. The strongest dietary correlate with vascular disease and hypercholesterolemia is the intake of saturate fat (1), and current recommendations include an increased proportion of polyunsaturated fatty acids in a diet with an overall reduction in total fat content of one-fourth or more. In most industrialized countries, the readily available polyunsaturatec are of the omega-6 class found in vegetable oils. Increased consumption of such fats in the place of saturated fats in dairy products has been accompanied by a continuous decline in cardiovascular disease rates in the United States (2), although decreased cigarette consumption and better treatment of hypertension have probably also contributed to this.

Keywords

Ambulatory Blood Pressure Vascular Reactivity Hypotensive Effect Fatty Acid Supplement Dietary Linoleic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    A Keys, Seven countries, a multivariate analysis of death and coronary heart disease. Cambridge, MA, and London A Commonwealth Fund Book, Harvard University Press (1980).Google Scholar
  2. 2.
    C. Lenfant and R.J. Hegyeli, Nonpharmacologic prevention of cardiovascular diseases in the United States, in: Nutritional Prevention of Cardiovascular Disease, W. Invenberg, Y. Yamori eds., Academic Press, Inc., Orlando, FL (1984).Google Scholar
  3. 3.
    N. Kromann and A. Greeland, Epidemiological Studies in the Upernavik District, Greenland, Acta Med Scan 208: 401 (1980).Google Scholar
  4. 4.
    A Leaf and P.C. Weber, Cardiovascular effects of n-3 fatty acids, New Eng J Med, 318:549 (1988).Google Scholar
  5. 5.
    C. Von Schacky, Prophylaxis of atherosclerosis with marine omega-3 fatty acids: a comprehensive strategy. Ann Intern Med, 107: 890 (1987).CrossRefGoogle Scholar
  6. 6.
    M.C. Smith, and M.J. Dunn, The role of prostaglandins in human hypertension, Hypertension and the Kidney: Proceedings of a Symposium, A32 (1985).Google Scholar
  7. 7.
    S.H. Goodnight, Jr., W.S. Harris, W. E. Connor, and D.R. Illingworth, Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 2: 87 (1982).CrossRefGoogle Scholar
  8. 8.
    G. Hornstra, E. Christ-Hazeihof, E. Haddeman, F. ten Hoor and D.H. Nugteren, Fish oil feeding lowers thromboxane-and prostacyclin production by rat platelets and aorta and does not result in the formation of prostaglandin I3. Prostaglandins 21: 727 (1981).PubMedCrossRefGoogle Scholar
  9. 9.
    L.K. Dahl, Salt and hypertension. Amer J Clin Nutr 25: 231 (1972).PubMedGoogle Scholar
  10. 10.
    I. Ehrstrom. Medical studies in North Greenland 1948–1949: VI. Blood pressure, hypertension and atherosclerosis in relation to food and mode of living. Acta Med Scand., 140: 416 (1951).CrossRefGoogle Scholar
  11. 11.
    P. Bjerager, N. Kromann, K. Thygesen, and B. Harvald. Blood pressure in Greenland Eskimos. Ugeskr Laeger, 142: 2278 (1980).PubMedGoogle Scholar
  12. 12.
    E.M. Scott, I.V. Griffith, D.D. Hoskins, R.D. and R.D. Whaley, Serum-cholesterol levels and blood-pressure of Alaskan Eskimo men. Lancet i: 667 (1958).Google Scholar
  13. 13.
    Y. Goto and Y. Hama, Recent trends of coronary heart disease in Japan in relation to dietary alteration. In: Nutritional Prevention of Cardiovascular Disease, W. Iovenberg and Y. Yamori eds., Academic Press, Orlando, FL (1984).Google Scholar
  14. 14.
    Y. Kagawa, M. Nishizawa, M. Suzuki, T. Midatake, T. Hamamoto, K Foto, E. Motonaga, H. Izumikawa, H. Hirata and A. Ebihara, Eicosapolyenoic acids of serum lipids of Japanese islanders with low incidence of cardiovascular diseases. J Nutr Sci Vitaminol 28: 441 (1982).PubMedCrossRefGoogle Scholar
  15. 15.
    T. Taminato, T. Matsumoto, K Suzuki, K. Sakamoto, N. Yasuda, S. Tsujimoto, T. Nakamura, and Y. Sasai, Mass spectrometric analysis of eicosapentaenoic acids in the serum of Japanese living on isolated islands and farming villages. In: Nutritional Prevention of Cardiovascular Disease, W. Lovenberg and Y. Yamori eds., Academic Press, Orlando, FL (1984).Google Scholar
  16. 16.
    T. Hamazaki, S. Fischer, M. Urakaze, S. Sawazaki and S. Yano. Comparison of the urinary metabolites of prostacyclin and thromboxane of the 2- and 3- series in a Japanese fishing and a Japanese farming village. Prostaglandins 32: 644 (1986).Google Scholar
  17. 17.
    I.A.M. Prior. Migration, hypertension, and pacific perspectives for prevention. In: Nutritional Prevention of Cardiovascular Disease, W. Lovenberg and Y. Yamori eds., Academic Press, Orlando, FL (1984).Google Scholar
  18. 18.
    T. Simonsen, A. Vartun, V. Lyngmo and A. Nordoy, Coronary heart disease, serum lipids, platelets and dietary fish in two communities in Northern Norway. Acta Med Scand 222: 237 (1987).PubMedCrossRefGoogle Scholar
  19. 19.
    W. E. Lockette, R. C. Webb, B. R. Culp and B. Pitt. Vascular reactivity and high dietary eicosapentaenoic acid. Prostaglandins 24: 631 (1982).PubMedCrossRefGoogle Scholar
  20. 20.
    D. E. Mills and R. P. Ward. Effects of eicosapentaenoic acid (20:5w3) on stress reactivity in rats. Proceedings of the Society for Experimental Biology and Medicine 182: 127 (1986).PubMedGoogle Scholar
  21. 21.
    B. A Scholkens, D. Gehring, V. Schlotte and U. Weithmann, Evening primose oil, a dietary prostaglandin precursor, diminishes vascular reactivity to renin and angiotensin II in rats. Prostaglandins, Leukotrines and Medicine 8:273 (1982).Google Scholar
  22. 22.
    L. Somova, P. Hoffman and W. Forster. The reactivity of isolated blood vessels of salt-loaded rats fed low or high linoleic acid diets. European J of Pharmacology 64: 79 (1980).CrossRefGoogle Scholar
  23. 23.
    R. Lorenz, U. Spengler, S. Fischer, J. Duhm and P.C. WPhPr. Platelet function, thromboxane formation and blood pressure control during supplementation of the Western diet with cod liver oil, Circulation 67: 504 (1983).PubMedCrossRefGoogle Scholar
  24. 24.
    F.B. Pipkin, R.A. Morrison and P. M. S. O’Brien. The effect of dietary supplementation with linoleic and y-linolenic acids on the pressor and biochemical response to exogenous angiotensin II in human pregnancy. PRog Lipid Res 25: 425 (1986).CrossRefGoogle Scholar
  25. 25.
    P. Singer, M. Wirth, S. Voigt, E. Richter-Heinrich, W. Godicke, I. Berger, E. Naumann, J. Listing, W. Hartrodt and C. Tauhe. Blood pressure-and lipid-lowering effect of mackerel and herring diet in patients with mild essential hypertension. Atherosclerosis 56: 223 (1985).PubMedCrossRefGoogle Scholar
  26. 26.
    H.R. Knapp and G.A. FitzGerald. Dietary polyunsaturates, blood pressure and vasodilator prostanoids. Clin Res 36: 357A (1988).Google Scholar
  27. 27.
    V. Hossmann, G. A. FitzGerald, and C. T. Dollery. Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension. Hypertension 3: 113 (1981).PubMedCrossRefGoogle Scholar
  28. 28.
    J. I. M. Drayer, M. A. Weber, and D. K. Nakamura. Automated ambulatory blood pressure monitoring: A study in age-matched normotensive and hypertensive men. Am Heart J 109: 1334 (1985).PubMedCrossRefGoogle Scholar
  29. 29.
    A I. Fleischman, M. L. Bierenbaum, A. Stier, H. Somol, P. Watson, and A. M. Naso. Hypotensive effect of increased dietary linoleic acid in mildly hypertensive humans. J of the Med Soc of NJ, 76:181 (1979).Google Scholar
  30. 30.
    H. U Comberg, S. Heyden and C. G. Hames. Hypotensive effect of dietary prostaglandin precursor in hypertensive man. Prostaglandins 15: 193 (1978).CrossRefGoogle Scholar
  31. 31.
    A. M. Heagerty, J. D. 011erenshaw, D. I. Robertson, R. F. Bing, and J. D. Swales. Influence of dietary linoleic acid on leucocyte sodium transport and blood pressure. British Med J 293: 295 (1986).CrossRefGoogle Scholar
  32. 32.
    J. M. Iacono, R. M. Dougherty and P. Puska. Reduction of blood pressure associated with dietary polyunsaturated fat. Hypertension 4 (supp III): III - 34 (1982).Google Scholar
  33. 33.
    B. M. Margetts, L. J. Beilin, B. K. Armstrong, I. L. Rous’, R. Vandogen, K. D. Croft and E. J. McMurchie. Blood pressure and dietary polyunsaturated and saturated fats: a controlled trial. Clin Sci 69: 165 (1985).PubMedGoogle Scholar
  34. 34.
    F. M. Sacks, M. J. Stampfer, A. Munoz, K. McManus, M. Canessa and E. H. Kass. Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. Journal of the American College of Nutrition, 6: 179 (1987).PubMedGoogle Scholar
  35. 35.
    T. A. B. Sanders, M. Vickers and A. P. Haines. Effect on blood lipids and haemostasis of a supplement of cod-liver oil, rich in eicosapentaenoic and docosahexaenoic acids, in healthy young men. Clin. Science 61: 371 (1981).Google Scholar
  36. 36.
    P. G. Norris, C. J. H. Jones, and M. J. Weston. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Brit Med J, 293: 104 (1986).CrossRefGoogle Scholar
  37. 37.
    P. B. Rylance, M. P. Gordge, R. Saynor, V. Parsons, and M. J. Weston. Fish oil modifies lipids and reduces platelet aggregability in haemodialysis patients. Nephron 43: 196 (1986).PubMedCrossRefGoogle Scholar
  38. 38.
    J. Z. Mortensen, E. B. Schmidt, A. H. Nielsen and J. Dyerberg. The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemostas 50: (2) 543 (1983).Google Scholar
  39. 39.
    D. M. Demke, G. R. Peters, O. I. Linet, C. M. Metzler and K. A. K lott. Effects of a fish oil concentrate in patients with hypercholesterolemia. Atherosclerosis 70: 73 (1988).PubMedCrossRefGoogle Scholar
  40. 40.
    T. Hamazaki, R. Nakazawa, S. Tateno, H. Shishido, K. Isoda, Y. Hattori, T. Yoshida, T. Fujita, S. Yano, and A. Kumagai. Effects of fish oil rich in eicosapentaenoic acid on serum lipid in hyperlipidemic hemodialysis patients. Kidney International, 26: 81 (1984).PubMedCrossRefGoogle Scholar
  41. 41.
    R. V. Houwelingen, A. Nordoy, E. van der Beek, U. Houtsmuller, M. de Metz and G. Hornstra. Effect of a moderate fish intake on blood pressure bleeding time, hematology, and clinical chemistry in healthy males. Am J Clin Nutr 46: 424 (1987).Google Scholar
  42. 42.
    S. Rogers, K. S. James, B. K. Butland, M. D. Etherington, J. R. O’Brien and J. G. Jones. Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and Theological variables. Atherosclerosis 63: 137 (1987).PubMedCrossRefGoogle Scholar
  43. 43.
    P. Singer, M. Wirth, S. Voigt, S. Zimontkowski, W. Godicke and H. Heine. Clinical studies on lipid and blood pressure lowering effect of eicosapentaenoic acid-rich diet. Biomed Biochim Acta 43: 8 /9, 5421 (1984).Google Scholar
  44. 44.
    P. Singer, I. Buyer, K. Luck, C. Taube, E. Naumann and W. Godicke. Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 62: 259 (1986).PubMedCrossRefGoogle Scholar
  45. 45.
    W. H. Seyberth, O. Oelz, and T. Kennedy, et al. Increased arachidonate in lipids after administration to man: Effects on prc~taglandin biosynthesis. Clin Pharmacol Ther 18: 521 (1975).PubMedGoogle Scholar
  46. 46.
    A. Ferretti, J. T. Judd, M. W. Marshall, V. P. Flanagan, J. M. Roman and E. J. Matusik, Jr. Moderate changes in linoleate intake do not influence the systemic production of E prostaglandins. Lipids 20:(5)268 (1985).Google Scholar
  47. 47.
    Adam, G. Wolfram, and N. Zollner. Prostaglandin formation in man during intake of different amounts of linoleic acid in formula diets. Ann Nutr Metab 26: 315 (1982).CrossRefGoogle Scholar
  48. 48.
    Z. Friedman, H. W. Seyberth, E. Latuberth, and J. A. Oates. Decreased prostaglandin E turnover in infants with essential fatty acid deficiency. Pediatr Res 12: 711 (1978).Google Scholar
  49. 49.
    H. R. Knapp, I. A. G. Reilly, P. Alessandrini, and G. A. FitzGerald. In vivo idexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis. N Eng J Med 314:937 (1986).Google Scholar
  50. 50.
    S. F Fischer and P. C. Weber. Prostaglandin I3 is formed in vivo in man after dietary eicosapentaenoic acid. Nature 307: 165 (1984).PubMedCrossRefGoogle Scholar
  51. 51.
    E. Zuccato, G. Hornstra and J. Dyerberg. Long term marine diet in Eskimos is not associated with altered urinary excretion of total tetranor prostagalndin metabolites. Prostaglandins 30(3):465(1985).Google Scholar
  52. 52.
    E. O’Brien, D. Fitzgerald, and K. O’Malley. Blood pressure measurement: current practice and future trends. Brit Med J 290: 729 (1985).CrossRefGoogle Scholar
  53. 53.
    C. Alicandri, R. Fariello, E. Boni, M. L. M.iesan, A. Zaninelli, E. Agabiti-Rosei, and G. Muiesan. Left ventricular hypertrophy and ambulatory monitoring of blood pressure. J Clin Hypertension, 3: 197 (1987).Google Scholar

Copyright information

© Springer Science+Business Media New York 1989

Authors and Affiliations

  • Howard Knapp
    • 1
  • Deborah Gregory
    • 1
  • Sharina Nolan
    • 1
  1. 1.Division of Clinical PharmacologyVanderbilt University NashvilleUSA

Personalised recommendations